priavoid.com
  • Home
  • About us
    • Overview
    • Strategy
    • Management
    • Supervisory Board
    • Scientific Advisory Board
    • History
  • Drug Development
    • Therapeutic Focus
    • Technology
    • Pipeline
  • Investors and Media
    • News
    • Events
    • Partnering
    • Archive
  • Contact us
    • Careers
Seite wählen

Prof. Willbold´s interview with PharmaVentures

November 14th, 2017

Learn more
Düsseldorf-Jülich Symposium on Neurodegenera7ve Diseases 2017 Bildquelle: Fotolia

Prof. Dieter Willbold talks with Summer Park of PharmaVentures at Biotech and Money Investival, London in 2017.

News & Events:

BIO.NRW MEDICA-FORUM

BIO.NRW MEDICA-FORUM

3. Dezember 2019
DGN Kongress 2019

DGN Kongress 2019

2. Oktober 2019
Seed Investment

Seed Investment

6. Mai 2019
CEOs of Priavoid

CEOs of Priavoid

3. Mai 2019
AD/PD 2019 – Lisbon

AD/PD 2019 – Lisbon

26. März 2019
BioRiver Boost! 2018

BioRiver Boost! 2018

23. Oktober 2018
The Nobel Prize

The Nobel Prize

5. Oktober 2018
Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018
ISO 9001:2015 certification

ISO 9001:2015 certification

7. Dezember 2017
Science September 7th, 2017

Science September 7th, 2017

10. September 2017
Clinical trial with PRI-002

Clinical trial with PRI-002

31. Mai 2017
  • Home
  • Investors and Media
  • Legal Notice
  • Privacy Policy
  • Contact us
Copyright © 2019 Priavoid GmbH